• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后用半量鱼精蛋白逆转肝素后拔除肱动脉鞘管的安全性分析:单中心经验

Safety analysis of brachial artery sheath removal after heparin reversal with a half dose of protamine after percutaneous coronary intervention: a single-center experience.

作者信息

Wang Huanhuan, Cui Cheng, Liu Dan, Liu Hongmei, Tian Tao, Liu Minghao, Zhang Bo, Zou Tongqiang, Gao Zhan, Gao Lijian, Liu Haibo

机构信息

Department of Cardiology, National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China.

Department of Cardiology, Shihezi People's Hospital, The Third Affiliated Hospital of Shihezi University School of Medicine, Xinjiang, China.

出版信息

Front Cardiovasc Med. 2025 Jan 6;11:1479506. doi: 10.3389/fcvm.2024.1479506. eCollection 2024.

DOI:10.3389/fcvm.2024.1479506
PMID:39882314
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11776300/
Abstract

AIM

To evaluate the safety of brachial artery (BA) sheath removal after heparin neutralization with a half dose of protamine immediately after percutaneous coronary intervention (PCI).

METHODS

The clinical data of 209 consecutive patients who underwent PCI through the BA at Fu Wai Hospital between September 2019 and June 2024 were retrospectively collected. In group I, the brachial sheath was removed 4 h after the PCI procedure. In group II, circulating heparin was neutralized with a half dose of protamine sulfate, and the brachial sheath was removed immediately after the procedure.

RESULTS

There were no cases of acute stent thrombosis, nonfatal myocardial infarction or in-hospital mortality in either group. In group II, there were two cases of pseudoaneurysm, one of which was transfer to surgery and the other was manually compressed. No severe puncture site-related bleeding occurred. The levels of hemoglobin were similar between the two groups before and after the PCI procedure ( > 0.05).

CONCLUSIONS

The BA sheath can be safely removed immediately after PCI by neutralizing heparin with a half dose of protamine. But we still need to be vigilant about the occurrence of pseudoaneurysms.

摘要

目的

评估经皮冠状动脉介入治疗(PCI)后立即用半剂量鱼精蛋白中和肝素后拔除肱动脉(BA)鞘管的安全性。

方法

回顾性收集2019年9月至2024年6月在阜外医院经肱动脉行PCI的209例连续患者的临床资料。I组在PCI术后4小时拔除肱动脉鞘管。II组用半剂量硫酸鱼精蛋白中和循环中的肝素,并在术后立即拔除肱动脉鞘管。

结果

两组均无急性支架血栓形成、非致死性心肌梗死或院内死亡病例。II组有2例假性动脉瘤,其中1例转手术治疗,另1例手法压迫。未发生严重的穿刺部位相关出血。两组PCI术前、术后血红蛋白水平相似(>0.05)。

结论

PCI后立即用半剂量鱼精蛋白中和肝素可安全拔除BA鞘管。但仍需警惕假性动脉瘤的发生。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1c/11776300/1ef9ce122b2b/fcvm-11-1479506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1c/11776300/7a3d6e73776d/fcvm-11-1479506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1c/11776300/1ef9ce122b2b/fcvm-11-1479506-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1c/11776300/7a3d6e73776d/fcvm-11-1479506-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a1c/11776300/1ef9ce122b2b/fcvm-11-1479506-g002.jpg

相似文献

1
Safety analysis of brachial artery sheath removal after heparin reversal with a half dose of protamine after percutaneous coronary intervention: a single-center experience.经皮冠状动脉介入治疗后用半量鱼精蛋白逆转肝素后拔除肱动脉鞘管的安全性分析:单中心经验
Front Cardiovasc Med. 2025 Jan 6;11:1479506. doi: 10.3389/fcvm.2024.1479506. eCollection 2024.
2
In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention.经皮冠状动脉介入治疗后使用鱼精蛋白逆转肝素作用后在实验室进行股动脉鞘移除。
EuroIntervention. 2005 May;1(1):66-9.
3
A randomized comparative study of using enoxaparin instead of unfractionated heparin in the intervention treatment of coronary heart disease.依诺肝素替代普通肝素用于冠心病介入治疗的随机对照研究
Chin Med J (Engl). 2006 Mar 5;119(5):355-9.
4
Immediate removal of femoral-sheath following protamine administration in patients undergoing intracoronary paclitaxel-eluting-stent implantation.在接受冠状动脉紫杉醇洗脱支架植入的患者中,给予鱼精蛋白后立即移除股鞘。
Expert Opin Pharmacother. 2007 Sep;8(13):2017-24. doi: 10.1517/14656566.8.13.2017.
5
Safety and efficacy of immediate heparin reversal with protamine after complex percutaneous coronary intervention.复杂经皮冠状动脉介入治疗后应用鱼精蛋白即刻逆转肝素的安全性和有效性。
BMC Cardiovasc Disord. 2022 May 10;22(1):207. doi: 10.1186/s12872-022-02650-5.
6
Safety of routine protamine in the reversal of heparin in percutaneous coronary intervention: A systematic review and meta-analysis.常规鱼精蛋白逆转经皮冠状动脉介入治疗中肝素的安全性:系统评价和荟萃分析。
Int J Cardiol. 2023 Oct 1;388:131168. doi: 10.1016/j.ijcard.2023.131168. Epub 2023 Jul 8.
7
Mid-term Clinical Outcomes of Immediate Protamine Use Following Elective Percutaneous Coronary Interventions.择期经皮冠状动脉介入治疗后立即使用鱼精蛋白的中期临床结果
Int Heart J. 2020 Sep 29;61(5):865-871. doi: 10.1536/ihj.20-126. Epub 2020 Sep 12.
8
Safety of immediate reversal of anticoagulation by protamine to reduce bleeding complications after infarct artery stenting for acute myocardial infarction and adjunctive abciximab therapy.在急性心肌梗死后梗死动脉支架置入术和联合使用阿昔单抗治疗中,鱼精蛋白即刻逆转抗凝以减少出血并发症的安全性。
J Thromb Thrombolysis. 2010 Nov;30(4):446-51. doi: 10.1007/s11239-010-0481-5.
9
Safety and complications associated with the use of protamine in percutaneous coronary intervention.经皮冠状动脉介入治疗中使用鱼精蛋白的安全性及并发症
J Invasive Cardiol. 2025 Jun;37(6). doi: 10.25270/jic/24.00336.
10
Low-dose protamine to facilitate earlier sheath removal from the femoral artery after peripheral endovascular intervention.经外周血管介入治疗后,低剂量鱼精蛋白有助于更早期地从股动脉鞘管中移除。
J Interv Cardiol. 2011 Jun;24(3):278-84. doi: 10.1111/j.1540-8183.2011.00642.x. Epub 2011 Apr 27.

本文引用的文献

1
Transbrachial Access Site Complications in Endovascular Interventions: A Systematic Review of the Literature.血管腔内介入治疗中经肱动脉入路部位并发症:文献系统综述
Cureus. 2022 Jun 13;14(6):e25894. doi: 10.7759/cureus.25894. eCollection 2022 Jun.
2
Distal transradial access for cardiac catheterization: A systematic scoping review.经桡动脉远端入路行心导管术:系统范围界定综述。
Catheter Cardiovasc Interv. 2020 Dec;96(7):1381-1389. doi: 10.1002/ccd.28623. Epub 2019 Nov 29.
3
2018 ESC/EACTS Guidelines on myocardial revascularization.
2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
4
Novel Distal Left Radial Artery Access in Anatomical Snuffbox for Recanalization of Proximal Radial Artery Total Occlusion and Percutaneous Coronary Intervention Through Left Internal Mammary Artery.用于桡动脉近端完全闭塞再通及经左内乳动脉进行经皮冠状动脉介入治疗的鼻烟窝处新型桡动脉远端入路
Circ Cardiovasc Interv. 2018 Jul;11(7):e006579. doi: 10.1161/CIRCINTERVENTIONS.118.006579.
5
Treatment of peripheral arterial disease via percutaneous brachial artery access.经皮肱动脉穿刺途径治疗外周动脉疾病。
J Vasc Surg. 2017 Aug;66(2):461-465. doi: 10.1016/j.jvs.2017.01.050. Epub 2017 Apr 19.
6
Percutaneous brachial artery access for coronary artery procedures: Feasible and safe in the current era.经皮肱动脉穿刺用于冠状动脉介入手术:在当今时代可行且安全。
Cardiovasc Revasc Med. 2015 Dec;16(8):447-9. doi: 10.1016/j.carrev.2015.08.004. Epub 2015 Aug 21.
7
Radial artery occlusion and hand strength after percutaneous coronary procedures: Results of the HANGAR study.经皮冠状动脉介入术后桡动脉闭塞与手部力量:HANGAR研究结果
Catheter Cardiovasc Interv. 2016 Apr;87(5):868-74. doi: 10.1002/ccd.26142. Epub 2015 Aug 13.
8
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南——总结
Diab Vasc Dis Res. 2014 May;11(3):133-73. doi: 10.1177/1479164114525548.
9
Forearm approach for percutaneous coronary procedures.经皮冠状动脉介入治疗的前臂入路
Acta Inform Med. 2013 Dec;21(4):283-7. doi: 10.5455/aim.2013.21.283-287. Epub 2013 Dec 4.
10
Third universal definition of myocardial infarction.心肌梗死的第三次全球定义。
Clin Biochem. 2013 Jan;46(1-2):1-4. doi: 10.1016/j.clinbiochem.2012.10.036. Epub 2012 Nov 2.